
Mierzwinski Endommetriose Polsko-Niemieckie Centrum Leczenia Endometriozysp. z o.o.
Specialist medical practice activities
KRS: NIP: REGON:
Overview
Status
Suspended
Registry date
2022-11-23
Share capital
5,000.00 PLN
Registered address
ul. Stanisława Wyspiańskiego 2, 41-949 Piekary Śląskie, Poland
Email
Financials
Revenue history
Filing timeliness
No financial statement for 2024 – the filing deadline has passed.
- 2024not filed
- 202327/03/2024
- 202231/03/2023
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2023.
Voivodeship · Śląskie46,664 / 51,326
Top 91%
Country · Poland447,006 / 495,867
Top 90%
Results vs industry
Revenue
This companyUSD 1.31kMedianUSD 443.52kAverageUSD 1.75m
Net profit
This companyUSD -964.25MedianUSD 14.31kAverageUSD 129.52k
Operating costs
This companyUSD 2.26kMedianUSD 397.10kAverageUSD 1.56m
Assets
This companyUSD 49.11MedianUSD 173.92kAverageUSD 1.02m
Industry
Authorized Representatives
Maciej Tomasz Mierzwińskiage 59 – President of the Management Board
Marcin Rafał Mierzwińskiage 54 – Management Board Member
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 50 | $675.31 | 50% | |
Marcin Rafał Mierzwińskiage 54 | 50 | $675.31 | 50% |
Maciej Tomasz Mierzwiński and Marcin Rafał Mierzwiński hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Centrum Medyczne Anmed Lifesp. z o.o. | $117,073.03 | anmedlife.pl | ||
| Med4fit - Poradnie Wielospecjalistycznesp. z o.o. | $103,909.70 | med4fit.pl | ||
| Centrum Terapii Familiasp. z o.o. | $89,486.54 | familia-gliwice.pl | ||
| Estesissp. z o.o. | $62,782.24 | estesis.pl | ||
| Nomedikasp. z o.o. | $34,820.10 | nomedika.pl | ||
| Polskie Szpitale Plastycznesp. z o.o. | $34,845.08 | stachura-drozd.com | ||
| Centrum Medyczne Corvitasp. z o.o. | $26,413.80 | corvita.pl | ||
| Centrum Medyczne Alexandra Clinicsp. z o.o. | $3,157.10 | alexandraclinic.pl | ||
| DR Knastsp. z o.o. | $1,785.53 | drknast.pl | ||
| Centrum Medyczne Tommedsp. z o.o. + limited partnership | $1,506.78 | tommed.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-05-13 | Business suspended | |
| 2025-07-20 | Business resumed | |
| 2023-07-19 | Business suspended | |
| 2022-11-23 | Entered in the register |
FAQ
The main business activity of Mierzwinski Endommetriose Polsko-Niemieckie Centrum Leczenia Endometriozy focuses on specialist medical practice activities.
The company was registered in the Polish National Court Register (KRS) on November 23, 2022.
The headquarters is located at: ul. Stanisława Wyspiańskiego 2, 41-949 Piekary Śląskie.
The management board consists of: Maciej Tomasz Mierzwiński (President of the Management Board) and Marcin Rafał Mierzwiński (Member of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.
The company reported a revenue of USD 1,315 in 2023.
No, the company recorded a net loss of USD 964 in 2023. For comparison, in 2022 the loss was USD 641, meaning the company increased its loss by 41.8%.
The largest operating cost category falls under external services. This category amounted to USD 2,072 in 2023, representing 92% of all operating expenses.
Last updated: 2026-08-27